2,6-diaminopurine has been researched along with deoxyguanosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Koga, M; Patil, SD; Schneller, SW; Snoeck, R | 1 |
| Cory, JG; Weckbecker, G | 1 |
| Andis, SL; Bewley, JR; Boder, GB; Burke, T; Dudley, DE; Eichelberger, LE; Grindey, GB; Grossman, CS; Hertel, LW; Jordan, CL | 1 |
3 other study(ies) available for 2,6-diaminopurine and deoxyguanosine
| Article | Year |
|---|---|
(+-)-carbocyclic 5'-nor-2'-deoxyguanosine and related purine derivatives: synthesis and antiviral properties.
Topics: 2-Aminopurine; Antiviral Agents; Cytomegalovirus; Deoxyadenosines; Deoxyguanosine; Herpesvirus 3, Human; HIV-1; HIV-2; Molecular Structure; Simplexvirus; Structure-Activity Relationship; Vaccinia virus; Vesicular stomatitis Indiana virus | 1992 |
2,6-Diaminopurinedeoxyriboside as a prodrug of deoxyguanosine in L1210 cells.
Topics: 2-Aminopurine; Adenosine Deaminase Inhibitors; Animals; Cell Division; Chromatography, High Pressure Liquid; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; DNA Replication; Dose-Response Relationship, Drug; Leukemia L1210; Ribonucleotide Reductases | 1987 |
Medicinal chemistry of difluoropurines.
Topics: 2-Aminopurine; Animals; Antineoplastic Agents; Blood Cell Count; Blood Pressure; Deoxyadenosines; Deoxyguanosine; Dogs; Drug Screening Assays, Antitumor; Female; Guanosine; Heart; Humans; In Vitro Techniques; Infusions, Intravenous; Injections, Intraperitoneal; Liver; Lymphoid Tissue; Male; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Structure-Activity Relationship; Testis | 1995 |